Current Suspected Overdose Deaths in Delaware for 2018: 259 logo

Delaware Health Alert Network #334

August 20, 2014 12:02 pm

Health Update


On April 12, 2013 the Centers for Disease Control and Prevention (CDC) announced a nationwide shortage of Tubersol®, one of two Purified Protein Derivative (PPD) tuberculin used in the Tuberculin Skin Test (TST) to diagnose TB infection. A shortage of Aplisol®, the second brand of PPD solution, was announced shortly after.

The shortage of PPD solution has now ended. The shortage of PPD solution Aplisol® was resolved May 2014, and the PPD solution Tubersol® was resolved in July 2014.


Resume testing in keeping with usual protocols.

Additional Information

Active TB disease is a legally reportable illness in Delaware, and the majority of cases are treated by specialists in DPH TB Clinics. To report a case of active TB, please contact the TB Clinic in your county or the TB Program.

  • DPH TB Elimination and Control Program
    • Ruth A. Fournier MSN, RN
      TB Program Manager/Nurse Consultant
  • DPH TB Clinics by County
    • New Castle: 302-283-7588
    • Kent: 302-857-5130
    • Sussex: 302-856-5119


  1. CDC Division of TB Elimination:

Categories of Health Alert messages:

  • Health Alert: Conveys the highest level of importance; warrants immediate action or attention.
  • Health Advisory: Provides important information for a specific incident or situation; may not require immediate action.
  • Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action.
NOTE: This page is for informational purposes only and dated material (e.g. temporary websites) may not be available.